This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor.—
I was fascinated with the article by Barkley et al1 on stimulant treatment for attention-deficit/hyperactivity disorder and risk of later drug abuse. The authors have tried to answer a question that worries many.
I am quite confused by their conclusion, which seems at clear odds with their data. They found, unfortunately, that treatment with stimulant medication in high school is significantly associated with the risk of ever trying cocaine. That this is a valid conclusion is supported by their finding that treatment with stimulant medication in childhood is associated with cocaine use in adulthood, although after adjusting for “disease severity” and the presence of conduct disorder, the association was no longer significant.
The authors work extraordinarily hard to explain to the reader why the first finding, which is statistically significant, is actually not real. The naïve reader may wonder why the authors are so invested in undermining their own carefully performed results.
It would make more sense to say that patients with conduct- disorder symptoms, or very severe attention-deficit symptoms, should not be treated with stimulant drugs because it appears that, in this subgroup, such treatment may be associated with an increased risk of cocaine use in adulthood. Or the authors could conclude that their population cannot answer the question that is being asked, because they did not compare a “treated with behavioral/psychotherapy plus stimulants” group versus a “treated with behavioral/psychotherapy without stimulants” group. In support of this conclusion, the authors do note …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.